- Home
- WW vs KRON Comparison
WW vs KRON Comparison
Compare WW & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WW
- KRON
- Stock Information
- Founded
- WW 1961
- KRON 2017
- Country
- WW United States
- KRON United States
- Employees
- WW N/A
- KRON N/A
- Industry
- WW Other Consumer Services
- KRON Medicinal Chemicals and Botanical Products
- Sector
- WW Consumer Discretionary
- KRON Health Care
- Exchange
- WW Nasdaq
- KRON Nasdaq
- Market Cap
- WW 75.9M
- KRON 61.5M
- IPO Year
- WW 2001
- KRON 2020
- Fundamental
- Price
- WW $0.53
- KRON $0.84
- Analyst Decision
- WW Buy
- KRON Buy
- Analyst Count
- WW 4
- KRON 3
- Target Price
- WW $3.44
- KRON $1.63
- AVG Volume (30 Days)
- WW 2.4M
- KRON 165.9K
- Earning Date
- WW 05-01-2025
- KRON 03-18-2025
- Dividend Yield
- WW N/A
- KRON N/A
- EPS Growth
- WW N/A
- KRON N/A
- EPS
- WW N/A
- KRON N/A
- Revenue
- WW $785,921,000.00
- KRON $9,848,000.00
- Revenue This Year
- WW N/A
- KRON N/A
- Revenue Next Year
- WW N/A
- KRON N/A
- P/E Ratio
- WW N/A
- KRON N/A
- Revenue Growth
- WW N/A
- KRON 56.62
- 52 Week Low
- WW $0.38
- KRON $0.69
- 52 Week High
- WW $2.35
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- WW 42.85
- KRON 31.82
- Support Level
- WW $0.48
- KRON $0.82
- Resistance Level
- WW $0.63
- KRON $0.95
- Average True Range (ATR)
- WW 0.06
- KRON 0.06
- MACD
- WW 0.01
- KRON -0.01
- Stochastic Oscillator
- WW 26.91
- KRON 10.94
About WW WW International Inc.
WW International Inc is a provider of weight loss solutions. The firm offers its members access to in person workshops and digital solutions as a part of its weight loss and weight management programs. Its digital app provides members access to tools such as, trackers for food, water, activity, weight, content regarding behavioral techniques for building healthy habits and other related tools. Along with its in person workshops and digital solutions, the company also provides members who medically qualify access to clinicians who can prescribe weight management medications when clinically appropriate. The company generates majority of its revenue in the form of Subscription Revenue. Geographically, the company generates key revenue from North America and rest from International markets.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.